Evidence map›Paper›PMID 32204571›Full record

ArticleMicroorganisms2020

OXA-48 Carbapenemase in

José E Villacís, Jorge A Reyes, Hugo G Castelán-Sánchez, Sonia Dávila-Ramos, Miguel Angel Lazo, Ahmad Wali, Luis A Bodero, Yadira Toapanta, Cristina Naranjo, Lorena Montero and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Clinical carbapenem-resistantMicrobiology spectrum · 2025
    Article
  3. CombatingFrontiers in cellular and infection microbiology · 2025
    Review
  4. Article
  5. Co-Harboring of Beta-Lactamases andAntibiotics (Basel, Switzerland) · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 4 countries.

José E VillacísFacultad de Medicina, Pontificia Universidad Católica del Ecuador, 170143 Quito, Ecuador.
Jorge A ReyesFacultad de Ciencias Químicas, Universidad Central del Ecuador, Quito 170129, Ecuador.
Hugo G Castelán-SánchezCentro de Investigación en Dinámica Celular, Instituto de Investigaciones Básicas y Aplicadas Universidad Autónoma del Estado de Morelos, Cuernavaca Morelos 62209, México.
Sonia Dávila-RamosCentro de Investigación en Dinámica Celular, Instituto de Investigaciones Básicas y Aplicadas Universidad Autónoma del Estado de Morelos, Cuernavaca Morelos 62209, México.
Miguel Angel LazoHospital de Especialidades Eugenio Espejo, Quito 170136, Ecuador.
Ahmad WaliHospital de Especialidades Eugenio Espejo, Quito 170136, Ecuador.
Luis A BoderoMinisterio de Salud Pública, 170702 Quito, Ecuador.
Yadira ToapantaHospital de Especialidades Eugenio Espejo, Quito 170136, Ecuador.
Cristina NaranjoHospital de Especialidades Eugenio Espejo, Quito 170136, Ecuador.
Lorena MonteroMinisterio de Salud Pública, 170702 Quito, Ecuador.
Josefina CamposAdministración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán," Buenos Aires 1281, Argentina.
Marcelo G GalasPan American Health Organization/WHO, Washington, DC 20037, USA.
Mónica C GestalLouisiana State University (LSU), Health Science Center, Shreveport, LA 71103, USA.
Hospital de Especialidades · MXMinisterio de Salud Pública · ECUniversidad Autónoma del Estado de Morelos · MXAdministración Nacional de Laboratorios e Institutos de Salud · ARCentral University of Ecuador · ECLouisiana State University Health Sciences Center Shreveport · USPontificia Universidad Católica del Ecuador · ECWorld Health Organization Regional Office for the Americas · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance is on the rise, leading to an increase in morbidity and mortality due to infectious diseases.

Indexed as

carbapenemase-producing EnterobacteralesKlebsiella pneumoniaeOXA-48 carbapenemase

Identifiers

PMID32204571
PMCPMC7143988
OpenAlexW3011538752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.